Discussion  by unknown
infected aortic graft and severe associated comorbid illness
who will not survive total graft excision, we believe preser-
vation of the infected main body of an aortic graft should be
considered as an option, provided the critical adjunctive
therapies are used.
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DISCUSSION
Dr John Ricotta (Stony Brook, NY). Keith, you may be
surprised that I agree with you. I think you and your group have
reviewed your experience with nonexcisional treatment and this
extends your previous work on your infrainguinal nonexcisional
treatment. I think in this group clearly the risks are a lot higher in
terms of failure often being coincident with mortality.
You’ve shown that in a subgroup of patients at very high risk
for graft removal, graft preservation can be achieved even when the
main body of the graft is involved. I agree with you that this is not
the optimal treatment of these patients, but I have had the oppor-
tunity to treat a couple of cases like this myself, one with necrotiz-
ing pancreatitis 10 days after an aortofemoral bypass and the other
with a colon ischemia and stool spillage. And both of those patients
actually did well over the long term.
That leads me to my first question: Do you think that there is
a difference in the patients that develop this acutely, you might say,
that it’s a contamination process rather than an established infec-
tion process? And if you can wash things out and establish appro-
priate drainage do you think that they may be better off than
somebody who’s got a prolonged infection?
I was a little surprised that you only used 6 weeks of antibiot-
ics. Certainly our experience has been to recommend lifelong
antibiotics for these patients. I wondered whether there were
reasons for that, whether the patients just didn’t want to take the
antibiotics or whether there was a problem with using lifelong
antibiotics or whether you felt that 6 weeks was enough. We have
had some late blowouts in people who have stopped antibiotics
when we’ve done partial graft excision. So I wonder if you could
comment on that.
You listed a number of patients who presented with groin
wound sepsis with involvement of the graft, and at least in the
paper you said this was confirmed by sinogram. Was total graft
infection documented in any other way, ie, an abscess around the
CT scan, or was the sinogram the way that total graft involvement
was identified? And if so, do you recommend that we do sinograms
on all of our patients with graft infection? Do you think somebody
with CT evidence of pus around the body of their aortic graft is
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different than somebody with a groin infection that lights up the
graft through a sinus?
You chose not to operate on several patients because of a hostile
abdomen. Certainly the cases that you represented bore that out. In
these cases, I presume that you did percutaneous drainage, since you
mentioned exposing the graft and putting drains in. I presume you
wouldn’t do that in a hostile abdomen. So in those patients, tell us
how you put the drains in, how you were sure that the drainage was
adequate. Since we know that a lot of drains after a relatively short
period of time seem to not really drain abscess cavities, how could you
tell when to pull the drains out?
I enjoyed the paper. I think that you’ve made an important
point, that in extreme cases graft preservation can be successful,
and it is obviously preferable when the experienced surgeon judges
that total excision is going to result in inevitable mortality. This is
a tough decision though. We saw patient 2’s brother about 3 weeks
ago. He had a ruptured aneurysm, loss of abdominal domain,
bowel rippling under skin, colostomy from colon ischemia, and he
presented with an aortoenteric fistula. Now, if it hadn’t been an
aortoenteric fistula, I would have done what you did. But obvi-
ously we couldn’t do that because he was actively bleeding. And
much to my surprise, he was able to tolerate axillobifemoral bypass
and total graft excision. So I think it’s still hard to tell which
patients are going to tolerate what.
I really congratulate you on the paper, because I think you’ve
shown that when we’re up against the wall, that there are good
alternatives to total graft excision.
Dr Keith D. Calligaro. Thanks, Dr. Ricotta, for your sup-
portive comments.
Your first question was: Is there a difference between acute
presentation versus delayed presentation of an infected or exposed
graft? It’s difficult to say in a series this small, but several of these
patients presented with infection several months or years after the
graft was placed.
In terms of duration of antibiotics administration, we gave IV
antibiotics for at least 6 weeks. Several of them received IV antibi-
otics for longer than that, and some received oral antibiotics for an
extended period of time. I don’t believe there are any good data on
what to do for these patients, quite frankly.
In terms of a sinogram, every patient in this series had a CAT
scan and/or operative findings that confirmed the presence of a
graft infection. Sinograms confirmed infection in a couple of
patients. Then they also had operative exploration that confirmed
there was fluid around the graft.
The next question concerned a hostile abdomen and drain
placement. You’re absolutely correct that if the abdomen was
hostile, it was impossible to place these operatively. A few patients
with hostile abdomens underwent percutaneous drain placement
and the drains were left until the cavity totally resolved.
Lastly, I think your last point was the most important, and we
agree, that the hardest part about this is making the decision about
whether you are going to try to preserve the graft or bite the bullet
and try to take the graft out. For some of the younger vascular
surgeons in the room, it can be a very, very difficult decision. It’s
difficult for me to give you specific criteria for how sick someone
has to be to consider this strategy.
Dr Alan M. Graham (New Brunswick, NJ). There has been a
lot of work from a number of institutions looking at the effect of
different bacteria species, yet you don’t mention in your presenta-
tion what the bacteria was—clearly a rampant Pseudomonas is quite
a different story than an indolent staph or even a strep. Can you just
comment on that?
Dr Calligaro. This was a small series of patients so it’s difficult
to determine whether there are any firm associations regarding
bacteria type and outcome.
But I would agree with you that Pseudomonas is clearly a bad
actor. The presence of this bacteria may be a factor that would sway
you to say, yes, we should take this graft out because it’s Pseudo-
monas as opposed to trying to preserve it.
Dr Richard F. Neville (Washington, DC). Just two quick
questions. In the groin infections, does involvement of the anas-
tomosis figure into your algorithm? We’ve had a number of these
cases; and when the anastomosis is involved, we are very con-
cerned, especially with a patent graft limb, about leaving that
intact.
Secondly, we’ve also found it very important to perform soft
tissue coverage with muscle flaps or viable tissue to try to help heal
things properly. Did you have any soft tissue techniques, or was
this just multiple debridements until things healed?
Dr Calligaro. The infection involved the groin in some of
these cases, but the abdominal portion of the graft was always
involved. We’re not presenting anyone with an infection confined
to the groin. In some of these patients, anastomosis was exposed. If
the patients had a pseudoaneurysm, that segment of graft and limb
had to come out. You can’t try to preserve a disrupted anastomosis
and you should never just try to oversew it.
Regarding use of a muscle flap, most of the patients in this
series were treated by wet-to-dry dressing changes and wound
healing by secondary intention. Nonetheless, we believe that mus-
cle flaps may serve a very useful role.
Dr Linda M. Harris (Buffalo, NY). My question has to do
with the follow-up of these patients. Obviously, it’s a very select
group who have made it through this procedure. How do you
recommend following them up? Are you doing serial CT scans,
ultrasounds? And if so, how frequently do you follow these pa-
tients?
Dr Calligaro. All of the patients underwent serial CAT scans
or duplex scans. We try to do them every 3 to 6 months after the
patients are doing well.
JOURNAL OF VASCULAR SURGERY
Volume 38, Number 6 Calligaro et al 1205
